A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONTES, Luciola de Barros et al. Physicians expertise in geriatric oncology care: a web survey among brazilian medical oncologists. 2014, Anais.. Chicago: ASCO, 2014. . Acesso em: 29 set. 2024.
APA
Pontes, L. de B., Gomes, D. B. D., Loureiro, L. V. M., Peria, F. M., Karnakis, T., Guendelmann, R. K., & Giglio, A. D. (2014). Physicians expertise in geriatric oncology care: a web survey among brazilian medical oncologists. In Abstracts. Chicago: ASCO.
NLM
Pontes L de B, Gomes DBD, Loureiro LVM, Peria FM, Karnakis T, Guendelmann RK, Giglio AD. Physicians expertise in geriatric oncology care: a web survey among brazilian medical oncologists. Abstracts. 2014 ;[citado 2024 set. 29 ]
Vancouver
Pontes L de B, Gomes DBD, Loureiro LVM, Peria FM, Karnakis T, Guendelmann RK, Giglio AD. Physicians expertise in geriatric oncology care: a web survey among brazilian medical oncologists. Abstracts. 2014 ;[citado 2024 set. 29 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARRARO, D. M. et al. Breast cancer gene expression profile in young women who are noncarriers of BRCA1/2 mutations with and without familial history. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/1538. Acesso em: 29 set. 2024. , 2010
APA
Carraro, D. M., Moreira-Filho, C. A., Ramos, P. L., Lisboa, B. C., Brentani, H., Achatz, M. W., et al. (2010). Breast cancer gene expression profile in young women who are noncarriers of BRCA1/2 mutations with and without familial history. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/1538
NLM
Carraro DM, Moreira-Filho CA, Ramos PL, Lisboa BC, Brentani H, Achatz MW, Folgueira MAK, Katayama MH, Brentani M. Breast cancer gene expression profile in young women who are noncarriers of BRCA1/2 mutations with and without familial history [Internet]. Journal of Clinical Oncology. 2010 ; 28( 15S ): 162s.[citado 2024 set. 29 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/1538
Vancouver
Carraro DM, Moreira-Filho CA, Ramos PL, Lisboa BC, Brentani H, Achatz MW, Folgueira MAK, Katayama MH, Brentani M. Breast cancer gene expression profile in young women who are noncarriers of BRCA1/2 mutations with and without familial history [Internet]. Journal of Clinical Oncology. 2010 ; 28( 15S ): 162s.[citado 2024 set. 29 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/1538
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, A. I. et al. Publication bias in randomized controlled trials (RCTs) of colorectal cancer presented at ASCO Annual Meetings. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/6116. Acesso em: 29 set. 2024. , 2010
APA
Leal, A. I., Barra, W. F., Saragiotto, D. F., Saad, E. D., & Hoff, P. M. (2010). Publication bias in randomized controlled trials (RCTs) of colorectal cancer presented at ASCO Annual Meetings. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/6116
NLM
Leal AI, Barra WF, Saragiotto DF, Saad ED, Hoff PM. Publication bias in randomized controlled trials (RCTs) of colorectal cancer presented at ASCO Annual Meetings [Internet]. Journal of Clinical Oncology. 2010 ; 28( 15S ): 476s.[citado 2024 set. 29 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/6116
Vancouver
Leal AI, Barra WF, Saragiotto DF, Saad ED, Hoff PM. Publication bias in randomized controlled trials (RCTs) of colorectal cancer presented at ASCO Annual Meetings [Internet]. Journal of Clinical Oncology. 2010 ; 28( 15S ): 476s.[citado 2024 set. 29 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/6116
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, G. et al. ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/5540. Acesso em: 29 set. 2024. , 2010
APA
Castro, G., Pasini, F. S., Siqueira, S. A., Ferraz, A. R., Villar, R. C., Snitcovsky, I. M., & Federico, M. H. (2010). ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/5540
NLM
Castro G, Pasini FS, Siqueira SA, Ferraz AR, Villar RC, Snitcovsky IM, Federico MH. ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT) [Internet]. Journal of Clinical Oncology. 2010 ; 28( 15S ): 431s.[citado 2024 set. 29 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/5540
Vancouver
Castro G, Pasini FS, Siqueira SA, Ferraz AR, Villar RC, Snitcovsky IM, Federico MH. ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT) [Internet]. Journal of Clinical Oncology. 2010 ; 28( 15S ): 431s.[citado 2024 set. 29 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/5540
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHADE, D. C. et al. Evaluation of recombinant bacillus Calmette-Guerin expressing pertussis toxin in bladder cancer. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/27/15S/3064?sid=fd23f8bf-7b03-4ee1-ac61-71d5e7687748. Acesso em: 29 set. 2024. , 2009
APA
Chade, D. C., Borra, R., Leite, K. R., Villanova, F. E., Nascimento, I., Liete, L. C., et al. (2009). Evaluation of recombinant bacillus Calmette-Guerin expressing pertussis toxin in bladder cancer. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/27/15S/3064?sid=fd23f8bf-7b03-4ee1-ac61-71d5e7687748
NLM
Chade DC, Borra R, Leite KR, Villanova FE, Nascimento I, Liete LC, Srougi M, Andrade PM. Evaluation of recombinant bacillus Calmette-Guerin expressing pertussis toxin in bladder cancer [Internet]. Journal of Clinical Oncology. 2009 ; 27( 15S ): 145s.[citado 2024 set. 29 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/27/15S/3064?sid=fd23f8bf-7b03-4ee1-ac61-71d5e7687748
Vancouver
Chade DC, Borra R, Leite KR, Villanova FE, Nascimento I, Liete LC, Srougi M, Andrade PM. Evaluation of recombinant bacillus Calmette-Guerin expressing pertussis toxin in bladder cancer [Internet]. Journal of Clinical Oncology. 2009 ; 27( 15S ): 145s.[citado 2024 set. 29 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/27/15S/3064?sid=fd23f8bf-7b03-4ee1-ac61-71d5e7687748
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETRILLI, A.S. et al. Fifteen years experience of the Brazilian Osteosarcoma Treatment Group (BOTG). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/27/15S/10039?sid=ed0a34dd-832c-4fbd-b8bf-4d96e7d74ccc. Acesso em: 29 set. 2024. , 2009
APA
Petrilli, A. S., Camargo, B. de, Odone Filho, V., Lustosa, D., Borsato, M. L., Calheiros, L. M., et al. (2009). Fifteen years experience of the Brazilian Osteosarcoma Treatment Group (BOTG). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/27/15S/10039?sid=ed0a34dd-832c-4fbd-b8bf-4d96e7d74ccc
NLM
Petrilli AS, Camargo B de, Odone Filho V, Lustosa D, Borsato ML, Calheiros LM, Brunetto AL, Barreto JH, Ferraro AA. Fifteen years experience of the Brazilian Osteosarcoma Treatment Group (BOTG) [Internet]. Journal of Clinical Oncology. 2009 ; 27( 15S ): 529s.[citado 2024 set. 29 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/27/15S/10039?sid=ed0a34dd-832c-4fbd-b8bf-4d96e7d74ccc
Vancouver
Petrilli AS, Camargo B de, Odone Filho V, Lustosa D, Borsato ML, Calheiros LM, Brunetto AL, Barreto JH, Ferraro AA. Fifteen years experience of the Brazilian Osteosarcoma Treatment Group (BOTG) [Internet]. Journal of Clinical Oncology. 2009 ; 27( 15S ): 529s.[citado 2024 set. 29 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/27/15S/10039?sid=ed0a34dd-832c-4fbd-b8bf-4d96e7d74ccc
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO JR., G. et al. Oral mucositis prevention by low-level laser therapy in head and neck cancer patients submitted to concurrent chemoradiation: A prospective randomized study. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/27/15S/6019?sid=0a9bbbd9-2e8c-40da-9902-61e6dd6449b8. Acesso em: 29 set. 2024. , 2009
APA
Castro Jr., G., Lima, A. G. de, Lopes, D. R., Ortegosa, M. V., Rosalmeida, M. C., Gil, E., et al. (2009). Oral mucositis prevention by low-level laser therapy in head and neck cancer patients submitted to concurrent chemoradiation: A prospective randomized study. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/27/15S/6019?sid=0a9bbbd9-2e8c-40da-9902-61e6dd6449b8
NLM
Castro Jr. G, Lima AG de, Lopes DR, Ortegosa MV, Rosalmeida MC, Gil E, Cavalcanti Leal AI, Federico MH, Villar RC, Snitcovsky I. Oral mucositis prevention by low-level laser therapy in head and neck cancer patients submitted to concurrent chemoradiation: A prospective randomized study [Internet]. Journal of Clinical Oncology. 2009 ; 27( 15S ): 305s.[citado 2024 set. 29 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/27/15S/6019?sid=0a9bbbd9-2e8c-40da-9902-61e6dd6449b8
Vancouver
Castro Jr. G, Lima AG de, Lopes DR, Ortegosa MV, Rosalmeida MC, Gil E, Cavalcanti Leal AI, Federico MH, Villar RC, Snitcovsky I. Oral mucositis prevention by low-level laser therapy in head and neck cancer patients submitted to concurrent chemoradiation: A prospective randomized study [Internet]. Journal of Clinical Oncology. 2009 ; 27( 15S ): 305s.[citado 2024 set. 29 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/27/15S/6019?sid=0a9bbbd9-2e8c-40da-9902-61e6dd6449b8
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, C. E. et al. Comparison of tolerability and efficacy of concurrent chemoradiation (CRT) for anal squamous cell carcinoma (SCC) in HIV-positive (HIV+) and -negative (HIV-) patients (pts). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/26/15_suppl/4606?sid=b63ac5bd-c8dc-4fd6-9860-dbee52d2c586. Acesso em: 29 set. 2024. , 2008
APA
Souza, C. E., Castro Jr., G., Saragiotto, D. F., Nadalin, W., Kiss, D. R., Nahas, C., et al. (2008). Comparison of tolerability and efficacy of concurrent chemoradiation (CRT) for anal squamous cell carcinoma (SCC) in HIV-positive (HIV+) and -negative (HIV-) patients (pts). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/26/15_suppl/4606?sid=b63ac5bd-c8dc-4fd6-9860-dbee52d2c586
NLM
Souza CE, Castro Jr. G, Saragiotto DF, Nadalin W, Kiss DR, Nahas C, Siqueira SA, Hoff PM. Comparison of tolerability and efficacy of concurrent chemoradiation (CRT) for anal squamous cell carcinoma (SCC) in HIV-positive (HIV+) and -negative (HIV-) patients (pts) [Internet]. Journal of Clinical Oncology. 2008 ; 26( 15S ): 239s.[citado 2024 set. 29 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/26/15_suppl/4606?sid=b63ac5bd-c8dc-4fd6-9860-dbee52d2c586
Vancouver
Souza CE, Castro Jr. G, Saragiotto DF, Nadalin W, Kiss DR, Nahas C, Siqueira SA, Hoff PM. Comparison of tolerability and efficacy of concurrent chemoradiation (CRT) for anal squamous cell carcinoma (SCC) in HIV-positive (HIV+) and -negative (HIV-) patients (pts) [Internet]. Journal of Clinical Oncology. 2008 ; 26( 15S ): 239s.[citado 2024 set. 29 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/26/15_suppl/4606?sid=b63ac5bd-c8dc-4fd6-9860-dbee52d2c586
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BEATO, C. A et al. Evaluation of quality of life (QoL) in 1,210 patients (pts) with metastic colorectal cancer (MCRC) treated with capecitabine (X) in Brazil: udated results from a large pt cohort with analysis a function of pts'ECOG PS. Journal of Clinical Oncology. alexandria: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 29 set. 2024. , 2006
APA
Beato, C. A., Van Eyll, B., Federico, M. H. H., Skare, N., Perdicaris, M. R., Franke, F. A., et al. (2006). Evaluation of quality of life (QoL) in 1,210 patients (pts) with metastic colorectal cancer (MCRC) treated with capecitabine (X) in Brazil: udated results from a large pt cohort with analysis a function of pts'ECOG PS. Journal of Clinical Oncology. alexandria: Faculdade de Medicina, Universidade de São Paulo.
NLM
Beato CA, Van Eyll B, Federico MHH, Skare N, Perdicaris MR, Franke FA, Oliveira C, Cabral C, Ribeiro R, Gampel O. Evaluation of quality of life (QoL) in 1,210 patients (pts) with metastic colorectal cancer (MCRC) treated with capecitabine (X) in Brazil: udated results from a large pt cohort with analysis a function of pts'ECOG PS. Journal of Clinical Oncology. 2006 ; 24( 18S ): 489s.[citado 2024 set. 29 ]
Vancouver
Beato CA, Van Eyll B, Federico MHH, Skare N, Perdicaris MR, Franke FA, Oliveira C, Cabral C, Ribeiro R, Gampel O. Evaluation of quality of life (QoL) in 1,210 patients (pts) with metastic colorectal cancer (MCRC) treated with capecitabine (X) in Brazil: udated results from a large pt cohort with analysis a function of pts'ECOG PS. Journal of Clinical Oncology. 2006 ; 24( 18S ): 489s.[citado 2024 set. 29 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, G. F et al. Ifosfamide (IFO) and doxorubicin (DOX) dose-intensities seem related to overall survival in adult soft-tissur sarcoma (STS) patients. Journal of Clinical Oncology. Alexandria, VA: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 29 set. 2024. , 2006
APA
Almeida, G. F., Castro Junior, G., Snitcovsky, I. M., Bassani, A. C., Diz, M. E., & Federico, M. H. H. (2006). Ifosfamide (IFO) and doxorubicin (DOX) dose-intensities seem related to overall survival in adult soft-tissur sarcoma (STS) patients. Journal of Clinical Oncology. Alexandria, VA: Faculdade de Medicina, Universidade de São Paulo.
NLM
Almeida GF, Castro Junior G, Snitcovsky IM, Bassani AC, Diz ME, Federico MHH. Ifosfamide (IFO) and doxorubicin (DOX) dose-intensities seem related to overall survival in adult soft-tissur sarcoma (STS) patients. Journal of Clinical Oncology. 2006 ; 24( 18S ): 540s.[citado 2024 set. 29 ]
Vancouver
Almeida GF, Castro Junior G, Snitcovsky IM, Bassani AC, Diz ME, Federico MHH. Ifosfamide (IFO) and doxorubicin (DOX) dose-intensities seem related to overall survival in adult soft-tissur sarcoma (STS) patients. Journal of Clinical Oncology. 2006 ; 24( 18S ): 540s.[citado 2024 set. 29 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOLGUEIRA, Maria Aparecida Azevedo Koike et al. Differential gene profiling of malignant cells and fibroblasts from the primary and metastatic sites from breast cancer patients upon stroma-epithelial cell interaction. Journal of Clinical Oncology. Alexandria: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 29 set. 2024. , 2006
APA
Folgueira, M. A. A. K., Honda, S. T., Benvenutti, T. T., Rozenchan, P. B., Santos, R. P., Brentani, H., et al. (2006). Differential gene profiling of malignant cells and fibroblasts from the primary and metastatic sites from breast cancer patients upon stroma-epithelial cell interaction. Journal of Clinical Oncology. Alexandria: Faculdade de Medicina, Universidade de São Paulo.
NLM
Folgueira MAAK, Honda ST, Benvenutti TT, Rozenchan PB, Santos RP, Brentani H, Carraro DM, Katayama MH, Lyra EC, Brentani MM. Differential gene profiling of malignant cells and fibroblasts from the primary and metastatic sites from breast cancer patients upon stroma-epithelial cell interaction. Journal of Clinical Oncology. 2006 ; 24( 18S ):[citado 2024 set. 29 ]
Vancouver
Folgueira MAAK, Honda ST, Benvenutti TT, Rozenchan PB, Santos RP, Brentani H, Carraro DM, Katayama MH, Lyra EC, Brentani MM. Differential gene profiling of malignant cells and fibroblasts from the primary and metastatic sites from breast cancer patients upon stroma-epithelial cell interaction. Journal of Clinical Oncology. 2006 ; 24( 18S ):[citado 2024 set. 29 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOFIORITO, C. M. et al. Chemokine receptor CXCR4 mRNA expression may be a marker of the presence of compromised lymph nodes in oral cavity squamous cell carcinoma. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 29 set. 2024. , 2005
APA
Campofiorito, C. M., Mangone, F. R. R., Pasini, F. S., Maistro, S., Snitcovsky, I. M. L., Walder, F., et al. (2005). Chemokine receptor CXCR4 mRNA expression may be a marker of the presence of compromised lymph nodes in oral cavity squamous cell carcinoma. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo.
NLM
Campofiorito CM, Mangone FRR, Pasini FS, Maistro S, Snitcovsky IML, Walder F, Lehn C, Carvalho MB, Brentani MM, Federico MH. Chemokine receptor CXCR4 mRNA expression may be a marker of the presence of compromised lymph nodes in oral cavity squamous cell carcinoma. Journal of Clinical Oncology. 2005 ; 23( 16S ): 866s.[citado 2024 set. 29 ]
Vancouver
Campofiorito CM, Mangone FRR, Pasini FS, Maistro S, Snitcovsky IML, Walder F, Lehn C, Carvalho MB, Brentani MM, Federico MH. Chemokine receptor CXCR4 mRNA expression may be a marker of the presence of compromised lymph nodes in oral cavity squamous cell carcinoma. Journal of Clinical Oncology. 2005 ; 23( 16S ): 866s.[citado 2024 set. 29 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, G. et al. Efficacy and safety of concurrent chemoradiotherapy (CCR) for unresectable locally advanced (ULA) head and neck squamous cell carcinoma (HNSCC). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 29 set. 2024. , 2005
APA
Castro, G., Snitcovsky, I. M. L., Gebrim, E. M., Leitao, G. M., Rocha, C. N., Nadalin, W., et al. (2005). Efficacy and safety of concurrent chemoradiotherapy (CCR) for unresectable locally advanced (ULA) head and neck squamous cell carcinoma (HNSCC). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo.
NLM
Castro G, Snitcovsky IML, Gebrim EM, Leitao GM, Rocha CN, Nadalin W, Ferraz AR, Federico MH. Efficacy and safety of concurrent chemoradiotherapy (CCR) for unresectable locally advanced (ULA) head and neck squamous cell carcinoma (HNSCC). Journal of Clinical Oncology. 2005 ; 23( 16S ): 522s.[citado 2024 set. 29 ]
Vancouver
Castro G, Snitcovsky IML, Gebrim EM, Leitao GM, Rocha CN, Nadalin W, Ferraz AR, Federico MH. Efficacy and safety of concurrent chemoradiotherapy (CCR) for unresectable locally advanced (ULA) head and neck squamous cell carcinoma (HNSCC). Journal of Clinical Oncology. 2005 ; 23( 16S ): 522s.[citado 2024 set. 29 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEGALLA, J et al. Evaluation of quality of life (QoL) in patients (pts) with metastatic colorectal cancer (MCRC) treated with capecitabine (X). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 29 set. 2024. , 2005
APA
Segalla, J., Eyll, B. van, Federico, M., Perdicaris, M., Cabral, S., Skare, N., et al. (2005). Evaluation of quality of life (QoL) in patients (pts) with metastatic colorectal cancer (MCRC) treated with capecitabine (X). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo.
NLM
Segalla J, Eyll B van, Federico M, Perdicaris M, Cabral S, Skare N, saltz E, Moura G, Filho U, Franke F. Evaluation of quality of life (QoL) in patients (pts) with metastatic colorectal cancer (MCRC) treated with capecitabine (X). Journal of Clinical Oncology. 2005 ; 23( 16S ): 751s.[citado 2024 set. 29 ]
Vancouver
Segalla J, Eyll B van, Federico M, Perdicaris M, Cabral S, Skare N, saltz E, Moura G, Filho U, Franke F. Evaluation of quality of life (QoL) in patients (pts) with metastatic colorectal cancer (MCRC) treated with capecitabine (X). Journal of Clinical Oncology. 2005 ; 23( 16S ): 751s.[citado 2024 set. 29 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HEGG, Roberto et al. Use of cholesterol-rich microemulsion that binds to low-density lipotein (LDL) receptors as avehicle for etoposide. American Society of Clinical Oncology. Chicago: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 29 set. 2024. , 2003
APA
Hegg, R., Carvalho, J., Graziani, S., Valduga, C. J., Fernandes, D. C., Azevedo, C. H. M., et al. (2003). Use of cholesterol-rich microemulsion that binds to low-density lipotein (LDL) receptors as avehicle for etoposide. American Society of Clinical Oncology. Chicago: Faculdade de Medicina, Universidade de São Paulo.
NLM
Hegg R, Carvalho J, Graziani S, Valduga CJ, Fernandes DC, Azevedo CHM, Lopes AC, Rodrigues DG, Maranhão RC. Use of cholesterol-rich microemulsion that binds to low-density lipotein (LDL) receptors as avehicle for etoposide. American Society of Clinical Oncology. 2003 ; 22 146.[citado 2024 set. 29 ]
Vancouver
Hegg R, Carvalho J, Graziani S, Valduga CJ, Fernandes DC, Azevedo CHM, Lopes AC, Rodrigues DG, Maranhão RC. Use of cholesterol-rich microemulsion that binds to low-density lipotein (LDL) receptors as avehicle for etoposide. American Society of Clinical Oncology. 2003 ; 22 146.[citado 2024 set. 29 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, G. et al. Carboplatin and etoposide (PE) combined with vincristine (V)-doxorubicin(AD)-cyclophosphamide (C) (VAdc) in ewing´s sarcoma (ES) primitive neuroectodermal tumor (PNET) in adults. 2001, Anais.. [S.l.]: Faculdade de Medicina, Universidade de São Paulo, 2001. . Acesso em: 29 set. 2024.
APA
Castro, G., Snitcovsky, I. M., Diniz, M. E., Folgueira, M. A., Brentani, M., & Federico, M. H. H. (2001). Carboplatin and etoposide (PE) combined with vincristine (V)-doxorubicin(AD)-cyclophosphamide (C) (VAdc) in ewing´s sarcoma (ES) primitive neuroectodermal tumor (PNET) in adults. In . Faculdade de Medicina, Universidade de São Paulo.
NLM
Castro G, Snitcovsky IM, Diniz ME, Folgueira MA, Brentani M, Federico MHH. Carboplatin and etoposide (PE) combined with vincristine (V)-doxorubicin(AD)-cyclophosphamide (C) (VAdc) in ewing´s sarcoma (ES) primitive neuroectodermal tumor (PNET) in adults. 2001 ;[citado 2024 set. 29 ]
Vancouver
Castro G, Snitcovsky IM, Diniz ME, Folgueira MA, Brentani M, Federico MHH. Carboplatin and etoposide (PE) combined with vincristine (V)-doxorubicin(AD)-cyclophosphamide (C) (VAdc) in ewing´s sarcoma (ES) primitive neuroectodermal tumor (PNET) in adults. 2001 ;[citado 2024 set. 29 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FEDERICO, Miriam Hatsue Honda et al. Transforming growth factor "beta"1, retinoic acid receptors RAR"alfa" and RAR"y" but not RAR"beta" mRNAs might bemarkes of nodal spread in oral squamous cell carcinomas. 2001, Anais.. [S.l.]: Faculdade de Medicina, Universidade de São Paulo, 2001. . Acesso em: 29 set. 2024.
APA
Federico, M. H. H., Pasini, F. S., Mangone, F. R., Kowalski, L. P., & Brentani, M. (2001). Transforming growth factor "beta"1, retinoic acid receptors RAR"alfa" and RAR"y" but not RAR"beta" mRNAs might bemarkes of nodal spread in oral squamous cell carcinomas. In . Faculdade de Medicina, Universidade de São Paulo.
NLM
Federico MHH, Pasini FS, Mangone FR, Kowalski LP, Brentani M. Transforming growth factor "beta"1, retinoic acid receptors RAR"alfa" and RAR"y" but not RAR"beta" mRNAs might bemarkes of nodal spread in oral squamous cell carcinomas. 2001 ;[citado 2024 set. 29 ]
Vancouver
Federico MHH, Pasini FS, Mangone FR, Kowalski LP, Brentani M. Transforming growth factor "beta"1, retinoic acid receptors RAR"alfa" and RAR"y" but not RAR"beta" mRNAs might bemarkes of nodal spread in oral squamous cell carcinomas. 2001 ;[citado 2024 set. 29 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBUTO, José Alexandre Marzagão et al. Correlation between serum tumor markers (TM) and stage: study in 75 patients (pts) with non-small cell lung cancer (NSCLC). 1997, Anais.. Denver: Instituto de Ciências Biomédicas, Universidade de São Paulo, 1997. . Acesso em: 29 set. 2024.
APA
Barbuto, J. A. M., Younes, R. N., Teixeira, E. A., Takimoto, N. R., Gross, J. L., Anelli, A., & Deheinzelin, D. (1997). Correlation between serum tumor markers (TM) and stage: study in 75 patients (pts) with non-small cell lung cancer (NSCLC). In Abstracts. Denver: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Barbuto JAM, Younes RN, Teixeira EA, Takimoto NR, Gross JL, Anelli A, Deheinzelin D. Correlation between serum tumor markers (TM) and stage: study in 75 patients (pts) with non-small cell lung cancer (NSCLC). Abstracts. 1997 ;[citado 2024 set. 29 ]
Vancouver
Barbuto JAM, Younes RN, Teixeira EA, Takimoto NR, Gross JL, Anelli A, Deheinzelin D. Correlation between serum tumor markers (TM) and stage: study in 75 patients (pts) with non-small cell lung cancer (NSCLC). Abstracts. 1997 ;[citado 2024 set. 29 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASSUMOTO, C. M. et al. Busulfan plus melphalan (bu/mel) followed by interleukin-2 (il-2) as a preparative regimen for autologus bone marrow transplantation for acute myelogenous leukemia. American Society of Clinical Oncology. Los Angeles: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 29 set. 2024. , 1995
APA
Massumoto, C. M., Ostronoff, M., Zambon, E., Almeida, M. C. de, Boehringer, B. L., Chamone, D. de A. F., & Dulley, F. L. (1995). Busulfan plus melphalan (bu/mel) followed by interleukin-2 (il-2) as a preparative regimen for autologus bone marrow transplantation for acute myelogenous leukemia. American Society of Clinical Oncology. Los Angeles: Faculdade de Medicina, Universidade de São Paulo.
NLM
Massumoto CM, Ostronoff M, Zambon E, Almeida MC de, Boehringer BL, Chamone D de AF, Dulley FL. Busulfan plus melphalan (bu/mel) followed by interleukin-2 (il-2) as a preparative regimen for autologus bone marrow transplantation for acute myelogenous leukemia. American Society of Clinical Oncology. 1995 ; 14 340.[citado 2024 set. 29 ]
Vancouver
Massumoto CM, Ostronoff M, Zambon E, Almeida MC de, Boehringer BL, Chamone D de AF, Dulley FL. Busulfan plus melphalan (bu/mel) followed by interleukin-2 (il-2) as a preparative regimen for autologus bone marrow transplantation for acute myelogenous leukemia. American Society of Clinical Oncology. 1995 ; 14 340.[citado 2024 set. 29 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACEDO, M. C. M. A. et al. Treatment of burkitt's lymphoma in adults with pediatric lmb protocol. American Society of Clinical Oncology. Los Angeles: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 29 set. 2024. , 1995
APA
Macedo, M. C. M. A., Boehringer, B. L., Ostronoff, M., Soussain, C., Conchon, M., Zambon, E., et al. (1995). Treatment of burkitt's lymphoma in adults with pediatric lmb protocol. American Society of Clinical Oncology. Los Angeles: Faculdade de Medicina, Universidade de São Paulo.
NLM
Macedo MCMA, Boehringer BL, Ostronoff M, Soussain C, Conchon M, Zambon E, Medeiros R, Dulley FL, Chamone D de AF. Treatment of burkitt's lymphoma in adults with pediatric lmb protocol. American Society of Clinical Oncology. 1995 ;14 396.[citado 2024 set. 29 ]
Vancouver
Macedo MCMA, Boehringer BL, Ostronoff M, Soussain C, Conchon M, Zambon E, Medeiros R, Dulley FL, Chamone D de AF. Treatment of burkitt's lymphoma in adults with pediatric lmb protocol. American Society of Clinical Oncology. 1995 ;14 396.[citado 2024 set. 29 ]